[{"Assets_0_Q2_USD":4143459000.0,"EarningsPerShareBasic_1_Q2_USD":0.17,"EarningsPerShareBasic_2_Q2_USD":0.59,"EarningsPerShareDiluted_1_Q2_USD":0.17,"EarningsPerShareDiluted_2_Q2_USD":0.58,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6200000.0,"NetIncomeLoss_2_Q2_USD":17448000.0,"NetIncomeLoss_1_Q2_USD":5035000.0,"StockholdersEquity_0_Q2_USD":2810997000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":29962000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":30006000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29613000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29597000.0,"Ticker":"BIO","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20170807"}]